IMPDH1 (Inosine Monophosphate Dehydrogenase 1) encodes the enzyme inosine monophosphate dehydrogenase type I, which catalyzes the NAD-dependent oxidation of IMP to XMP, the rate-limiting step in de novo guanine nucleotide biosynthesis. While traditionally studied in the context of cancer immunotherapy and antiviral therapy, IMPDH1 has emerging roles in neuronal function and has been implicated in several neurodegenerative diseases.
- Gene Symbol: IMPDH1
- Official Name: Inosine-5'-monophosphate dehydrogenase 1
- Chromosomal Location: 7q31.3
- NCBI Gene ID: 3616
- Uniprot ID: P20839
¶ Protein Structure and Function
IMPDH1 is a homomeric enzyme with the following characteristics:
- Quaternary structure: Tetrameric enzyme (four identical subunits)
- Molecular weight: ~56 kDa per subunit
- Cofactor requirement: NAD+ as electron acceptor
- Substrate specificity: IMP (inosine monophosphate)
- IMP binds to the active site
- NAD+ oxidizes IMP at C2 position, forming XMP (xanthosine monophosphate)
- NADH is released
- XMP is further converted to GMP by GMP synthetase
IMPDH1 has multiple splice variants with tissue-specific expression patterns.
- Brain: Expressed in neurons throughout the CNS, particularly in:
- Cerebral cortex
- Hippocampus (CA1-CA3 regions)
- Cerebellum (Purkinje cells)
- Retina (photoreceptor cells)
- Lymphocytes: High expression in proliferating T and B cells
- Other tissues: Heart, kidney, liver
¶ Retinitis Pigmentosa and Neurological Disease
IMPDH1 mutations cause a distinct form of retinitis pigmentosa (RP) known as RP10, characterized by:
- Progressive retinal degeneration
- Visual field constriction
- Night blindness beginning in adolescence
- Variable neurological features including:
- Hearing loss
- Ataxia
- Mild cognitive impairment
The R105P and D226N mutations are among the most studied pathogenic variants [1][2].
IMPDH1 may play indirect roles in Alzheimer's disease pathogenesis:
- Purine metabolism dysregulation: IMPDH1 expression is altered in AD brains, affecting GTP pools critical for synaptic function [3]
- Amyloid-beta effects: Aβ can modulate IMPDH1 expression in neurons [4]
- Tau pathology: GTP depletion through IMPDH1 dysfunction may affect tau phosphorylation [5]
- Energy metabolism: Guanine nucleotides are essential for mitochondrial function
- Dopaminergic neuron vulnerability: IMPDH1 activity may be particularly important for dopaminergic neuron survival [6]
- L-DOPA metabolism: The purine pathway intersects with dopamine biosynthesis
- Mitochondrial function: GTP is required for mitochondrial DNA maintenance
- Motor neuron metabolism: High metabolic demand of motor neurons requires robust nucleotide synthesis [7]
- RNA metabolism: IMPDH1 provides GTP for RNA synthesis and processing
- Protein synthesis: GTP is needed for translational machinery
- Mycophenolate mofetil (CellCept): An IMPDH inhibitor used in transplant and autoimmune diseases
- Tiazofurin: A nucleoside analogue IMPDH inhibitor
- Ribavirin: Antiviral with IMPDH inhibitory activity
- Blood-brain barrier penetration is limited for most IMPDH inhibitors
- Systemic inhibition causes immunosuppression
- May have different effects on neurons vs. other cell types
- cAMP/PKA signaling: GTP modulates G-protein signaling
- mTOR pathway: GTP availability affects mTORC1 activity
- Synaptic plasticity: Local GTP synthesis regulates spine morphology
- Myelin maintenance: Oligodendrocyte GTP needs
- GMP synthetase (GMPS): Downstream enzyme in GMP synthesis
- GMP reductase (GMPR): Alternative pathway for GMP metabolism
- Adenylate kinases: Energy metabolism
- Cytoskeletal proteins: For subcellular localization
¶ Mutations and Disease
- RP10 mutations: R105P, A134D, R231H, D226N
- Dominant inheritance: Most pathogenic variants act in a dominant-negative manner
- Variable expressivity: Phenotype severity varies by mutation
- Various SNPs in IMPDH1 have been studied for:
- Cancer susceptibility
- Response to immunosuppressive therapy
- IMPDH1 knockout mice: Show retinal degeneration and immunodeficiency
- CRISPR models: Human neuronal models with IMPDH1 mutations
- Small molecule probes: Fluorescent substrates for activity measurement
Additional evidence sources: